Effect of COVID-19 coronavirus infection on the course of rheumatoid arthritis
Open Access
- 14 May 2022
- journal article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 60 (2), 157-161
- https://doi.org/10.47360/1995-4484-2022-157-161
Abstract
To date, there are numerous studies on the effect of COVID-19 on the course of autoimmune rheumatic diseases and the value of vaccination in preventing this dangerous viral infection.Objective: to assess the effect of coronavirus infection on the course of rheumatoid arthritis (RA), the severity of infection, the effect of current baseline therapy on infection outcomes, and the role of vaccination against COVID-19.Patients and methods. 134 patients with a reliable diagnosis of RA were interviewed and their outpatient records analysed during the pandemic period from January 2020 to July 2021.Results. Most of the patients were in the older age group (62.7 years on average), had an average disease duration of 13 years, low to moderate RA activity, comorbidities including arterial hypertension, excess body weight, type 2 diabetes mellitus, etc. All patients received synthetic basic anti-inflammatory drugs (BАID) and glucocorticoids (GC). Thirtyseven (27.6%) patients were vaccinated with the Sputnik V vaccine. Their adverse events were represented by soreness at the injection site (n=6) and transient flu-like syndrome (n=6). Worsening of joint syndrome was reported by 1 patient. COVID-19 was suffered by 43 patients, none of whom were vaccinated. 7 patients were hospitalized, 3 patients died (all had severe comorbidities). In the post-infection period, weakness (64%), memory impairment (48.7%), reduced ability to work (38.5%) persisted for a long time (42 days on average), which was due to the long withdrawal of BАID.Conclusion. No exacerbations of the disease were noted in those vaccinated with Sputnik V. COVID-19 was detected in 43 (32.1%) patients, 7 of whom required hospitalization and 3 died. Exacerbation of RA in the post-infection period was associated with prolonged withdrawal of BАID.This publication has 13 references indexed in Scilit:
- Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of RussiaRheumatology Science and Practice, 2021
- Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk IndividualsArthritis & Rheumatology, 2021
- Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysisIntensive Care Medicine, 2021
- Coronavirus disease 2019 (COVID-19) and autoimmunityRheumatology Science and Practice, 2021
- COVID-19 and rheumatology: A year laterRheumatology Science and Practice, 2021
- Patterns of the rheumatic disease course in the setting of a new coronavirus infectionRussian Medical Review, 2021
- Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19Cells, 2020
- No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany)Annals Of The Rheumatic Diseases, 2020
- COVID-19 revisiting inflammatory pathways of arthritisNature Reviews Rheumatology, 2020
- Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based studyAnnals Of The Rheumatic Diseases, 2020